Drug patents hold back innovation (GAO report)

Article
The basic problem is that the law in the US allows patenting of drugs that differ very little from existing drugs. Most effort in patenting new drugs goes to such minor “innovations”.
The GAO report can be downloaded in PDF format.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s